nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ABCB1—melanoma	0.737	1	CbGaD
Atenolol—Procarbazine—CYP1B1—melanoma	0.00534	0.479	CrCbGaD
Atenolol—Colitis ischaemic—Docetaxel—melanoma	0.00431	0.0225	CcSEcCtD
Atenolol—Atrial flutter—Docetaxel—melanoma	0.00333	0.0174	CcSEcCtD
Atenolol—Atrial fibrillation—Vemurafenib—melanoma	0.00285	0.0149	CcSEcCtD
Atenolol—Digestion impaired—Temozolomide—melanoma	0.00285	0.0149	CcSEcCtD
Atenolol—Pain in extremity—Vemurafenib—melanoma	0.00271	0.0141	CcSEcCtD
Atenolol—Aggression—Bleomycin—melanoma	0.00257	0.0134	CcSEcCtD
Atenolol—Cholestasis—Temozolomide—melanoma	0.00251	0.0131	CcSEcCtD
Atenolol—Systemic lupus erythematosus—Docetaxel—melanoma	0.00229	0.0119	CcSEcCtD
Atenolol—Wheezing—Bleomycin—melanoma	0.00219	0.0114	CcSEcCtD
Atenolol—Hepatic enzyme increased—Temozolomide—melanoma	0.00201	0.0105	CcSEcCtD
Atenolol—Supraventricular tachycardia—Docetaxel—melanoma	0.00193	0.0101	CcSEcCtD
Atenolol—Disorientation—Bleomycin—melanoma	0.00183	0.00956	CcSEcCtD
Atenolol—Dry eye—Temozolomide—melanoma	0.00176	0.00918	CcSEcCtD
Atenolol—Throat sore—Docetaxel—melanoma	0.00176	0.00917	CcSEcCtD
Atenolol—Oropharyngeal discomfort—Docetaxel—melanoma	0.00174	0.00909	CcSEcCtD
Atenolol—Rash erythematous—Docetaxel—melanoma	0.00165	0.00863	CcSEcCtD
Atenolol—Alopecia—Vemurafenib—melanoma	0.00165	0.00863	CcSEcCtD
Atenolol—Lethargy—Dactinomycin—melanoma	0.00156	0.00814	CcSEcCtD
Atenolol—Vascular purpura—Temozolomide—melanoma	0.00155	0.00806	CcSEcCtD
Atenolol—Amnesia—Carmustine—melanoma	0.00152	0.00795	CcSEcCtD
Atenolol—Nasal congestion—Temozolomide—melanoma	0.00152	0.00792	CcSEcCtD
Atenolol—Hot flush—Temozolomide—melanoma	0.00148	0.00771	CcSEcCtD
Atenolol—Amnesia—Temozolomide—melanoma	0.00147	0.00768	CcSEcCtD
Atenolol—Menopausal symptoms—Temozolomide—melanoma	0.00147	0.00765	CcSEcCtD
Atenolol—Dermatitis exfoliative—Temozolomide—melanoma	0.00147	0.00765	CcSEcCtD
Atenolol—Purpura—Temozolomide—melanoma	0.00143	0.00748	CcSEcCtD
Atenolol—Cough—Vemurafenib—melanoma	0.00142	0.00742	CcSEcCtD
Atenolol—Bronchospasm—Bleomycin—melanoma	0.00139	0.00727	CcSEcCtD
Atenolol—Oropharyngeal pain—Docetaxel—melanoma	0.00139	0.00727	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00138	0.00718	CcSEcCtD
Atenolol—Affect lability—Temozolomide—melanoma	0.00136	0.0071	CcSEcCtD
Atenolol—Ataxia—Carmustine—melanoma	0.00135	0.00702	CcSEcCtD
Atenolol—Mood swings—Temozolomide—melanoma	0.00131	0.00683	CcSEcCtD
Atenolol—Ibuprofen—BCL2—melanoma	0.00131	0.117	CrCbGaD
Atenolol—Ataxia—Temozolomide—melanoma	0.0013	0.00678	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00124	0.0065	CcSEcCtD
Atenolol—Hypotension—Vemurafenib—melanoma	0.00124	0.00648	CcSEcCtD
Atenolol—Myocardial infarction—Bleomycin—melanoma	0.00124	0.00646	CcSEcCtD
Atenolol—Decreased appetite—Vemurafenib—melanoma	0.00116	0.00603	CcSEcCtD
Atenolol—Gastrointestinal disorder—Vemurafenib—melanoma	0.00115	0.00599	CcSEcCtD
Atenolol—Fatigue—Vemurafenib—melanoma	0.00115	0.00598	CcSEcCtD
Atenolol—Constipation—Vemurafenib—melanoma	0.00114	0.00593	CcSEcCtD
Atenolol—Lightheadedness—Docetaxel—melanoma	0.00113	0.00591	CcSEcCtD
Atenolol—Pulmonary oedema—Docetaxel—melanoma	0.00113	0.00588	CcSEcCtD
Atenolol—Erectile dysfunction—Temozolomide—melanoma	0.0011	0.00574	CcSEcCtD
Atenolol—Depression—Carmustine—melanoma	0.0011	0.00574	CcSEcCtD
Atenolol—Agranulocytosis—Dactinomycin—melanoma	0.0011	0.00574	CcSEcCtD
Atenolol—Renal failure—Carmustine—melanoma	0.00108	0.00565	CcSEcCtD
Atenolol—Depression—Temozolomide—melanoma	0.00106	0.00554	CcSEcCtD
Atenolol—Flushing—Bleomycin—melanoma	0.00105	0.00549	CcSEcCtD
Atenolol—Body temperature increased—Vemurafenib—melanoma	0.00105	0.00548	CcSEcCtD
Atenolol—Ibuprofen—CXCL8—melanoma	0.00105	0.0939	CrCbGaD
Atenolol—Cardiac failure congestive—Docetaxel—melanoma	0.00101	0.00529	CcSEcCtD
Atenolol—Alopecia—Bleomycin—melanoma	0.001	0.00523	CcSEcCtD
Atenolol—Hallucination—Carmustine—melanoma	0.000985	0.00514	CcSEcCtD
Atenolol—Hot flush—Docetaxel—melanoma	0.000983	0.00513	CcSEcCtD
Atenolol—Flushing—Dactinomycin—melanoma	0.000981	0.00512	CcSEcCtD
Atenolol—Menopausal symptoms—Docetaxel—melanoma	0.000974	0.00508	CcSEcCtD
Atenolol—Visual disturbance—Docetaxel—melanoma	0.00097	0.00506	CcSEcCtD
Atenolol—Atrial fibrillation—Docetaxel—melanoma	0.00097	0.00506	CcSEcCtD
Atenolol—Asthenia—Vemurafenib—melanoma	0.000954	0.00498	CcSEcCtD
Atenolol—Visual impairment—Carmustine—melanoma	0.000954	0.00498	CcSEcCtD
Atenolol—Hallucination—Temozolomide—melanoma	0.000952	0.00497	CcSEcCtD
Atenolol—Cardiac failure—Docetaxel—melanoma	0.000942	0.00492	CcSEcCtD
Atenolol—Pruritus—Vemurafenib—melanoma	0.000941	0.00491	CcSEcCtD
Atenolol—Lethargy—Docetaxel—melanoma	0.000938	0.0049	CcSEcCtD
Atenolol—Alopecia—Dactinomycin—melanoma	0.000934	0.00488	CcSEcCtD
Atenolol—Visual impairment—Temozolomide—melanoma	0.000922	0.00481	CcSEcCtD
Atenolol—Pain in extremity—Docetaxel—melanoma	0.000919	0.0048	CcSEcCtD
Atenolol—Flushing—Carmustine—melanoma	0.000919	0.00479	CcSEcCtD
Atenolol—Ill-defined disorder—Bleomycin—melanoma	0.000916	0.00478	CcSEcCtD
Atenolol—Diarrhoea—Vemurafenib—melanoma	0.00091	0.00475	CcSEcCtD
Atenolol—Tinnitus—Temozolomide—melanoma	0.000892	0.00465	CcSEcCtD
Atenolol—Malaise—Bleomycin—melanoma	0.00089	0.00464	CcSEcCtD
Atenolol—Flushing—Temozolomide—melanoma	0.000888	0.00463	CcSEcCtD
Atenolol—Arrhythmia—Carmustine—melanoma	0.000884	0.00461	CcSEcCtD
Atenolol—Dizziness—Vemurafenib—melanoma	0.000879	0.00459	CcSEcCtD
Atenolol—Alopecia—Carmustine—melanoma	0.000875	0.00456	CcSEcCtD
Atenolol—Ataxia—Docetaxel—melanoma	0.000864	0.00451	CcSEcCtD
Atenolol—Cough—Bleomycin—melanoma	0.000861	0.00449	CcSEcCtD
Atenolol—Ill-defined disorder—Dactinomycin—melanoma	0.000854	0.00446	CcSEcCtD
Atenolol—Alopecia—Temozolomide—melanoma	0.000845	0.00441	CcSEcCtD
Atenolol—Chest pain—Bleomycin—melanoma	0.00084	0.00438	CcSEcCtD
Atenolol—Orthostatic hypotension—Docetaxel—melanoma	0.00084	0.00438	CcSEcCtD
Atenolol—Rash—Vemurafenib—melanoma	0.000838	0.00437	CcSEcCtD
Atenolol—Dermatitis—Vemurafenib—melanoma	0.000838	0.00437	CcSEcCtD
Atenolol—Headache—Vemurafenib—melanoma	0.000833	0.00435	CcSEcCtD
Atenolol—Discomfort—Bleomycin—melanoma	0.00083	0.00433	CcSEcCtD
Atenolol—Malaise—Dactinomycin—melanoma	0.00083	0.00433	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000828	0.00432	CcSEcCtD
Atenolol—Confusional state—Bleomycin—melanoma	0.000812	0.00424	CcSEcCtD
Atenolol—Vision blurred—Carmustine—melanoma	0.000812	0.00424	CcSEcCtD
Atenolol—Oedema—Bleomycin—melanoma	0.000806	0.0042	CcSEcCtD
Atenolol—Nausea—Vemurafenib—melanoma	0.00079	0.00412	CcSEcCtD
Atenolol—Thrombocytopenia—Bleomycin—melanoma	0.000789	0.00412	CcSEcCtD
Atenolol—Vision blurred—Temozolomide—melanoma	0.000785	0.00409	CcSEcCtD
Atenolol—Bronchospasm—Docetaxel—melanoma	0.000782	0.00408	CcSEcCtD
Atenolol—Discomfort—Dactinomycin—melanoma	0.000774	0.00404	CcSEcCtD
Atenolol—Ill-defined disorder—Temozolomide—melanoma	0.000772	0.00403	CcSEcCtD
Atenolol—Anorexia—Bleomycin—melanoma	0.000768	0.00401	CcSEcCtD
Atenolol—Hypotension—Bleomycin—melanoma	0.000753	0.00393	CcSEcCtD
Atenolol—Oedema—Dactinomycin—melanoma	0.000751	0.00392	CcSEcCtD
Atenolol—Malaise—Temozolomide—melanoma	0.000751	0.00392	CcSEcCtD
Atenolol—Vertigo—Temozolomide—melanoma	0.000748	0.0039	CcSEcCtD
Atenolol—Palpitations—Temozolomide—melanoma	0.000736	0.00384	CcSEcCtD
Atenolol—Thrombocytopenia—Dactinomycin—melanoma	0.000736	0.00384	CcSEcCtD
Atenolol—Chest pain—Carmustine—melanoma	0.000733	0.00383	CcSEcCtD
Atenolol—Anxiety—Carmustine—melanoma	0.000731	0.00381	CcSEcCtD
Atenolol—Cough—Temozolomide—melanoma	0.000727	0.00379	CcSEcCtD
Atenolol—Ibuprofen—PPARG—melanoma	0.000723	0.0649	CrCbGaD
Atenolol—Paraesthesia—Bleomycin—melanoma	0.000723	0.00377	CcSEcCtD
Atenolol—Dyspnoea—Bleomycin—melanoma	0.000718	0.00375	CcSEcCtD
Atenolol—Anorexia—Dactinomycin—melanoma	0.000716	0.00374	CcSEcCtD
Atenolol—Confusional state—Carmustine—melanoma	0.000709	0.0037	CcSEcCtD
Atenolol—Anxiety—Temozolomide—melanoma	0.000706	0.00369	CcSEcCtD
Atenolol—Oedema—Carmustine—melanoma	0.000703	0.00367	CcSEcCtD
Atenolol—Discomfort—Temozolomide—melanoma	0.0007	0.00365	CcSEcCtD
Atenolol—Decreased appetite—Bleomycin—melanoma	0.0007	0.00365	CcSEcCtD
Atenolol—Renal failure—Docetaxel—melanoma	0.000696	0.00363	CcSEcCtD
Atenolol—Myocardial infarction—Docetaxel—melanoma	0.000695	0.00362	CcSEcCtD
Atenolol—Dry mouth—Temozolomide—melanoma	0.000693	0.00362	CcSEcCtD
Atenolol—Pain—Bleomycin—melanoma	0.000689	0.00359	CcSEcCtD
Atenolol—Thrombocytopenia—Carmustine—melanoma	0.000688	0.00359	CcSEcCtD
Atenolol—Tachycardia—Carmustine—melanoma	0.000686	0.00358	CcSEcCtD
Atenolol—Confusional state—Temozolomide—melanoma	0.000685	0.00358	CcSEcCtD
Atenolol—Chlorphenesin—PTGS2—melanoma	0.000684	0.0613	CrCbGaD
Atenolol—Oedema—Temozolomide—melanoma	0.000679	0.00355	CcSEcCtD
Atenolol—Anorexia—Carmustine—melanoma	0.00067	0.0035	CcSEcCtD
Atenolol—Epistaxis—Docetaxel—melanoma	0.000668	0.00349	CcSEcCtD
Atenolol—Thrombocytopenia—Temozolomide—melanoma	0.000665	0.00347	CcSEcCtD
Atenolol—Feeling abnormal—Bleomycin—melanoma	0.000664	0.00346	CcSEcCtD
Atenolol—Agranulocytosis—Docetaxel—melanoma	0.000661	0.00345	CcSEcCtD
Atenolol—Hypotension—Carmustine—melanoma	0.000657	0.00343	CcSEcCtD
Atenolol—Hyperhidrosis—Temozolomide—melanoma	0.000657	0.00343	CcSEcCtD
Atenolol—Decreased appetite—Dactinomycin—melanoma	0.000653	0.00341	CcSEcCtD
Atenolol—Fatigue—Dactinomycin—melanoma	0.000648	0.00338	CcSEcCtD
Atenolol—Anorexia—Temozolomide—melanoma	0.000648	0.00338	CcSEcCtD
Atenolol—Pain—Dactinomycin—melanoma	0.000642	0.00335	CcSEcCtD
Atenolol—Body temperature increased—Bleomycin—melanoma	0.000637	0.00332	CcSEcCtD
Atenolol—Insomnia—Carmustine—melanoma	0.000636	0.00332	CcSEcCtD
Atenolol—Paraesthesia—Carmustine—melanoma	0.000631	0.00329	CcSEcCtD
Atenolol—Dyspnoea—Carmustine—melanoma	0.000627	0.00327	CcSEcCtD
Atenolol—Somnolence—Carmustine—melanoma	0.000625	0.00326	CcSEcCtD
Atenolol—Feeling abnormal—Dactinomycin—melanoma	0.000619	0.00323	CcSEcCtD
Atenolol—Insomnia—Temozolomide—melanoma	0.000615	0.00321	CcSEcCtD
Atenolol—Visual impairment—Docetaxel—melanoma	0.000613	0.0032	CcSEcCtD
Atenolol—Decreased appetite—Carmustine—melanoma	0.000611	0.00319	CcSEcCtD
Atenolol—Paraesthesia—Temozolomide—melanoma	0.00061	0.00318	CcSEcCtD
Atenolol—Gastrointestinal disorder—Carmustine—melanoma	0.000607	0.00317	CcSEcCtD
Atenolol—Dyspnoea—Temozolomide—melanoma	0.000606	0.00316	CcSEcCtD
Atenolol—Somnolence—Temozolomide—melanoma	0.000604	0.00315	CcSEcCtD
Atenolol—Constipation—Carmustine—melanoma	0.000601	0.00314	CcSEcCtD
Atenolol—Pain—Carmustine—melanoma	0.000601	0.00314	CcSEcCtD
Atenolol—Dyspepsia—Temozolomide—melanoma	0.000598	0.00312	CcSEcCtD
Atenolol—Body temperature increased—Dactinomycin—melanoma	0.000594	0.0031	CcSEcCtD
Atenolol—Decreased appetite—Temozolomide—melanoma	0.000591	0.00308	CcSEcCtD
Atenolol—Flushing—Docetaxel—melanoma	0.00059	0.00308	CcSEcCtD
Atenolol—Gastrointestinal disorder—Temozolomide—melanoma	0.000587	0.00306	CcSEcCtD
Atenolol—Fatigue—Temozolomide—melanoma	0.000586	0.00306	CcSEcCtD
Atenolol—Constipation—Temozolomide—melanoma	0.000581	0.00303	CcSEcCtD
Atenolol—Pain—Temozolomide—melanoma	0.000581	0.00303	CcSEcCtD
Atenolol—Feeling abnormal—Carmustine—melanoma	0.000579	0.00302	CcSEcCtD
Atenolol—Asthenia—Bleomycin—melanoma	0.000578	0.00302	CcSEcCtD
Atenolol—Pruritus—Bleomycin—melanoma	0.00057	0.00297	CcSEcCtD
Atenolol—Arrhythmia—Docetaxel—melanoma	0.000568	0.00296	CcSEcCtD
Atenolol—Alopecia—Docetaxel—melanoma	0.000562	0.00293	CcSEcCtD
Atenolol—Feeling abnormal—Temozolomide—melanoma	0.00056	0.00292	CcSEcCtD
Atenolol—Body temperature increased—Carmustine—melanoma	0.000556	0.0029	CcSEcCtD
Atenolol—Asthenia—Dactinomycin—melanoma	0.000539	0.00281	CcSEcCtD
Atenolol—Body temperature increased—Temozolomide—melanoma	0.000537	0.0028	CcSEcCtD
Atenolol—Acebutolol—ABCB1—melanoma	0.000537	0.0481	CrCbGaD
Atenolol—Diarrhoea—Dactinomycin—melanoma	0.000514	0.00268	CcSEcCtD
Atenolol—Rash—Bleomycin—melanoma	0.000508	0.00265	CcSEcCtD
Atenolol—Dermatitis—Bleomycin—melanoma	0.000507	0.00265	CcSEcCtD
Atenolol—Asthenia—Carmustine—melanoma	0.000504	0.00263	CcSEcCtD
Atenolol—Syncope—Docetaxel—melanoma	0.000497	0.00259	CcSEcCtD
Atenolol—Palpitations—Docetaxel—melanoma	0.000489	0.00255	CcSEcCtD
Atenolol—Asthenia—Temozolomide—melanoma	0.000488	0.00254	CcSEcCtD
Atenolol—Loss of consciousness—Docetaxel—melanoma	0.000487	0.00254	CcSEcCtD
Atenolol—Cough—Docetaxel—melanoma	0.000483	0.00252	CcSEcCtD
Atenolol—Diarrhoea—Carmustine—melanoma	0.000481	0.00251	CcSEcCtD
Atenolol—Pruritus—Temozolomide—melanoma	0.000481	0.00251	CcSEcCtD
Atenolol—Nausea—Bleomycin—melanoma	0.000478	0.0025	CcSEcCtD
Atenolol—Rash—Dactinomycin—melanoma	0.000474	0.00247	CcSEcCtD
Atenolol—Chest pain—Docetaxel—melanoma	0.000471	0.00246	CcSEcCtD
Atenolol—Dizziness—Carmustine—melanoma	0.000465	0.00243	CcSEcCtD
Atenolol—Diarrhoea—Temozolomide—melanoma	0.000465	0.00243	CcSEcCtD
Atenolol—Dry mouth—Docetaxel—melanoma	0.000461	0.00241	CcSEcCtD
Atenolol—Confusional state—Docetaxel—melanoma	0.000456	0.00238	CcSEcCtD
Atenolol—Metoprolol—ABCB1—melanoma	0.000453	0.0406	CrCbGaD
Atenolol—Oedema—Docetaxel—melanoma	0.000452	0.00236	CcSEcCtD
Atenolol—Dizziness—Temozolomide—melanoma	0.000449	0.00234	CcSEcCtD
Atenolol—Nausea—Dactinomycin—melanoma	0.000446	0.00233	CcSEcCtD
Atenolol—Shock—Docetaxel—melanoma	0.000445	0.00232	CcSEcCtD
Atenolol—Rash—Carmustine—melanoma	0.000443	0.00231	CcSEcCtD
Atenolol—Dermatitis—Carmustine—melanoma	0.000443	0.00231	CcSEcCtD
Atenolol—Thrombocytopenia—Docetaxel—melanoma	0.000442	0.00231	CcSEcCtD
Atenolol—Tachycardia—Docetaxel—melanoma	0.000441	0.0023	CcSEcCtD
Atenolol—Headache—Carmustine—melanoma	0.00044	0.0023	CcSEcCtD
Atenolol—Anorexia—Docetaxel—melanoma	0.000431	0.00225	CcSEcCtD
Atenolol—Rash—Temozolomide—melanoma	0.000428	0.00224	CcSEcCtD
Atenolol—Dermatitis—Temozolomide—melanoma	0.000428	0.00223	CcSEcCtD
Atenolol—Headache—Temozolomide—melanoma	0.000426	0.00222	CcSEcCtD
Atenolol—Hypotension—Docetaxel—melanoma	0.000422	0.0022	CcSEcCtD
Atenolol—Nausea—Carmustine—melanoma	0.000418	0.00218	CcSEcCtD
Atenolol—Insomnia—Docetaxel—melanoma	0.000409	0.00213	CcSEcCtD
Atenolol—Paraesthesia—Docetaxel—melanoma	0.000406	0.00212	CcSEcCtD
Atenolol—Nausea—Temozolomide—melanoma	0.000404	0.00211	CcSEcCtD
Atenolol—Dyspnoea—Docetaxel—melanoma	0.000403	0.0021	CcSEcCtD
Atenolol—Somnolence—Docetaxel—melanoma	0.000402	0.0021	CcSEcCtD
Atenolol—Dyspepsia—Docetaxel—melanoma	0.000398	0.00208	CcSEcCtD
Atenolol—Decreased appetite—Docetaxel—melanoma	0.000393	0.00205	CcSEcCtD
Atenolol—Gastrointestinal disorder—Docetaxel—melanoma	0.00039	0.00204	CcSEcCtD
Atenolol—Fatigue—Docetaxel—melanoma	0.00039	0.00203	CcSEcCtD
Atenolol—Pain—Docetaxel—melanoma	0.000386	0.00202	CcSEcCtD
Atenolol—Constipation—Docetaxel—melanoma	0.000386	0.00202	CcSEcCtD
Atenolol—Feeling abnormal—Docetaxel—melanoma	0.000372	0.00194	CcSEcCtD
Atenolol—Body temperature increased—Docetaxel—melanoma	0.000357	0.00186	CcSEcCtD
Atenolol—Asthenia—Docetaxel—melanoma	0.000324	0.00169	CcSEcCtD
Atenolol—Pruritus—Docetaxel—melanoma	0.00032	0.00167	CcSEcCtD
Atenolol—Diarrhoea—Docetaxel—melanoma	0.000309	0.00161	CcSEcCtD
Atenolol—Ibuprofen—PTGS2—melanoma	0.000305	0.0274	CrCbGaD
Atenolol—Dizziness—Docetaxel—melanoma	0.000299	0.00156	CcSEcCtD
Atenolol—Rash—Docetaxel—melanoma	0.000285	0.00149	CcSEcCtD
Atenolol—Dermatitis—Docetaxel—melanoma	0.000285	0.00149	CcSEcCtD
Atenolol—Headache—Docetaxel—melanoma	0.000283	0.00148	CcSEcCtD
Atenolol—Ibuprofen—ALB—melanoma	0.000272	0.0244	CrCbGaD
Atenolol—Nausea—Docetaxel—melanoma	0.000268	0.0014	CcSEcCtD
Atenolol—Ibuprofen—ABCB1—melanoma	0.00026	0.0233	CrCbGaD
Atenolol—Propranolol—ABCB1—melanoma	0.000229	0.0205	CrCbGaD
Atenolol—ADRB1—GPCR downstream signaling—PRKCA—melanoma	4.03e-05	0.000667	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCR2—melanoma	4.03e-05	0.000666	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CXCL8—melanoma	4.03e-05	0.000666	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	3.99e-05	0.00066	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—WNT5A—melanoma	3.99e-05	0.00066	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VEGFC—melanoma	3.99e-05	0.00066	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RAC2—melanoma	3.97e-05	0.000655	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PRKCA—melanoma	3.95e-05	0.000652	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—EDN1—melanoma	3.91e-05	0.000646	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—WNT5A—melanoma	3.9e-05	0.000645	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VEGFC—melanoma	3.9e-05	0.000645	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	3.89e-05	0.000643	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	3.85e-05	0.000636	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—EDN1—melanoma	3.82e-05	0.000632	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CSF2—melanoma	3.82e-05	0.000632	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	3.76e-05	0.000622	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	3.75e-05	0.00062	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—RAC1—melanoma	3.74e-05	0.000618	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CSF2—melanoma	3.74e-05	0.000618	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	3.73e-05	0.000617	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PRKCA—melanoma	3.66e-05	0.000606	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—RAC1—melanoma	3.66e-05	0.000605	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LUM—melanoma	3.64e-05	0.000601	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PHGDH—melanoma	3.64e-05	0.000601	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PRKCA—melanoma	3.58e-05	0.000592	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MAP2K2—melanoma	3.58e-05	0.000592	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HPSE—melanoma	3.57e-05	0.000589	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MAP2K2—melanoma	3.5e-05	0.000579	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—F2R—melanoma	3.5e-05	0.000579	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CUBN—melanoma	3.5e-05	0.000578	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—F2R—melanoma	3.43e-05	0.000566	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—RAC1—melanoma	3.4e-05	0.000561	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EDNRB—melanoma	3.39e-05	0.000561	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.39e-05	0.00056	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CSPG4—melanoma	3.38e-05	0.000559	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—BSG—melanoma	3.38e-05	0.000559	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SDHD—melanoma	3.38e-05	0.000559	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—RAC1—melanoma	3.32e-05	0.000549	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EDNRB—melanoma	3.32e-05	0.000549	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTK2B—melanoma	3.29e-05	0.000544	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GPAM—melanoma	3.27e-05	0.000541	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTK2B—melanoma	3.22e-05	0.000533	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.21e-05	0.00053	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GAB2—melanoma	3.2e-05	0.00053	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GNA11—melanoma	3.2e-05	0.00053	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FLT1—melanoma	3.19e-05	0.000527	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CG—melanoma	3.16e-05	0.000522	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GNA11—melanoma	3.13e-05	0.000518	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GAB2—melanoma	3.13e-05	0.000518	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FLT1—melanoma	3.12e-05	0.000516	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.12e-05	0.000515	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	3.09e-05	0.000511	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.05e-05	0.000504	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.05e-05	0.000504	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FOXO4—melanoma	3.01e-05	0.000498	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HDAC2—melanoma	3.01e-05	0.000498	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCR4—melanoma	3.01e-05	0.000498	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GNAQ—melanoma	2.98e-05	0.000492	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HDAC2—melanoma	2.95e-05	0.000487	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FOXO4—melanoma	2.95e-05	0.000487	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCR4—melanoma	2.95e-05	0.000487	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GNAQ—melanoma	2.91e-05	0.000482	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.9e-05	0.00048	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.88e-05	0.000476	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CG—melanoma	2.87e-05	0.000474	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CG—melanoma	2.81e-05	0.000464	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SYK—melanoma	2.8e-05	0.000463	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PLA2G6—melanoma	2.78e-05	0.00046	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	2.78e-05	0.000459	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ITGAV—melanoma	2.75e-05	0.000454	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NGFR—melanoma	2.75e-05	0.000454	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT3—melanoma	2.75e-05	0.000454	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SYK—melanoma	2.74e-05	0.000453	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	2.72e-05	0.000449	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ITGAV—melanoma	2.69e-05	0.000444	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NGFR—melanoma	2.69e-05	0.000444	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT3—melanoma	2.69e-05	0.000444	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.65e-05	0.000438	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.56e-05	0.000423	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SOCS1—melanoma	2.55e-05	0.000421	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	2.54e-05	0.00042	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—S100B—melanoma	2.54e-05	0.00042	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	2.52e-05	0.000417	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—VCAN—melanoma	2.5e-05	0.000413	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SOCS1—melanoma	2.49e-05	0.000412	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	2.48e-05	0.000411	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—S100B—melanoma	2.48e-05	0.000411	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	2.47e-05	0.000408	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ERBB4—melanoma	2.43e-05	0.000401	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	2.42e-05	0.0004	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN2B—melanoma	2.41e-05	0.000398	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ERBB4—melanoma	2.38e-05	0.000393	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	2.37e-05	0.000392	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN2B—melanoma	2.35e-05	0.000389	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CD86—melanoma	2.33e-05	0.000385	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	2.33e-05	0.000385	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EDN1—melanoma	2.31e-05	0.000382	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CD86—melanoma	2.28e-05	0.000376	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	2.28e-05	0.000376	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EDN1—melanoma	2.26e-05	0.000373	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CSF2—melanoma	2.26e-05	0.000373	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGF1—melanoma	2.26e-05	0.000373	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—IL2—melanoma	2.22e-05	0.000368	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—E2F1—melanoma	2.21e-05	0.000365	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CSF2—melanoma	2.21e-05	0.000365	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGF1—melanoma	2.21e-05	0.000365	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	2.2e-05	0.000363	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	2.19e-05	0.000361	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—IL2—melanoma	2.18e-05	0.00036	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PRKCA—melanoma	2.16e-05	0.000358	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ITGB3—melanoma	2.16e-05	0.000358	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.16e-05	0.000357	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—E2F1—melanoma	2.16e-05	0.000357	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	2.15e-05	0.000356	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	2.14e-05	0.000353	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SPP1—melanoma	2.12e-05	0.000351	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ITGB3—melanoma	2.12e-05	0.00035	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRKCA—melanoma	2.12e-05	0.00035	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	2.12e-05	0.00035	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	2.11e-05	0.000349	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP17A1—melanoma	2.11e-05	0.000349	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SPP1—melanoma	2.08e-05	0.000343	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	2.07e-05	0.000342	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	2.07e-05	0.000342	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL2—melanoma	2.02e-05	0.000334	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TERT—melanoma	2.01e-05	0.000333	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RAC1—melanoma	2.01e-05	0.000332	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GNA11—melanoma	1.99e-05	0.000329	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL2—melanoma	1.98e-05	0.000327	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TERT—melanoma	1.97e-05	0.000325	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RAC1—melanoma	1.96e-05	0.000324	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.95e-05	0.000323	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—FASN—melanoma	1.95e-05	0.000322	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HIF1A—melanoma	1.92e-05	0.000318	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC5A5—melanoma	1.92e-05	0.000317	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HIF1A—melanoma	1.88e-05	0.000311	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GNAQ—melanoma	1.85e-05	0.000306	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CD44—melanoma	1.85e-05	0.000306	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KDR—melanoma	1.84e-05	0.000304	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KDR—melanoma	1.8e-05	0.000298	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP1B1—melanoma	1.78e-05	0.000293	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FN1—melanoma	1.77e-05	0.000293	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	1.73e-05	0.000287	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FN1—melanoma	1.73e-05	0.000286	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CD80—melanoma	1.7e-05	0.000281	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	1.7e-05	0.00028	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APC—melanoma	1.7e-05	0.00028	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	1.7e-05	0.00028	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KIT—melanoma	1.7e-05	0.00028	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—NRAS—melanoma	1.7e-05	0.00028	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EGF—melanoma	1.68e-05	0.000277	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CD80—melanoma	1.66e-05	0.000275	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KIT—melanoma	1.66e-05	0.000274	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APC—melanoma	1.66e-05	0.000274	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	1.66e-05	0.000274	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—NRAS—melanoma	1.66e-05	0.000274	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EGF—melanoma	1.64e-05	0.000271	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	1.62e-05	0.000268	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—BRAF—melanoma	1.59e-05	0.000263	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	1.59e-05	0.000262	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—BRAF—melanoma	1.56e-05	0.000258	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1—melanoma	1.55e-05	0.000257	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	1.54e-05	0.000255	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—EGFR—melanoma	1.54e-05	0.000255	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1—melanoma	1.52e-05	0.000251	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	1.51e-05	0.00025	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—EGFR—melanoma	1.51e-05	0.00025	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	1.5e-05	0.000248	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	1.49e-05	0.000246	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	1.48e-05	0.000244	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	1.47e-05	0.000243	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—KRAS—melanoma	1.46e-05	0.000241	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	1.46e-05	0.000241	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	1.44e-05	0.000239	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—KRAS—melanoma	1.43e-05	0.000236	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGF2—melanoma	1.43e-05	0.000236	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGF2—melanoma	1.4e-05	0.000231	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PRKCA—melanoma	1.35e-05	0.000222	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	1.34e-05	0.000222	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MDM2—melanoma	1.34e-05	0.000221	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ERCC2—melanoma	1.33e-05	0.000221	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ERBB2—melanoma	1.32e-05	0.000218	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	1.31e-05	0.000217	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MDM2—melanoma	1.31e-05	0.000216	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	1.3e-05	0.000215	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ERBB2—melanoma	1.29e-05	0.000213	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	1.27e-05	0.00021	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCL8—melanoma	1.25e-05	0.000206	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—HRAS—melanoma	1.24e-05	0.000205	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCL8—melanoma	1.22e-05	0.000202	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	1.22e-05	0.000201	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—HRAS—melanoma	1.21e-05	0.000201	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	1.21e-05	0.000199	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CASP3—melanoma	1.19e-05	0.000197	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL2—melanoma	1.19e-05	0.000197	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	1.19e-05	0.000197	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL6—melanoma	1.19e-05	0.000196	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	1.18e-05	0.000195	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CASP3—melanoma	1.17e-05	0.000193	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL2—melanoma	1.17e-05	0.000193	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCND1—melanoma	1.16e-05	0.000192	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL6—melanoma	1.16e-05	0.000192	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	1.15e-05	0.00019	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCND1—melanoma	1.14e-05	0.000188	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MMP9—melanoma	1.13e-05	0.000187	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	1.13e-05	0.000186	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	1.13e-05	0.000186	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTEN—melanoma	1.12e-05	0.000186	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NFKB1—melanoma	1.12e-05	0.000185	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MMP9—melanoma	1.1e-05	0.000183	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	1.1e-05	0.000182	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTEN—melanoma	1.1e-05	0.000181	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT1—melanoma	1.1e-05	0.000181	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NFKB1—melanoma	1.09e-05	0.000181	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT1—melanoma	1.07e-05	0.000177	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CG—melanoma	1.05e-05	0.000174	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARG—melanoma	1.02e-05	0.000168	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VEGFA—melanoma	1.01e-05	0.000168	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STAT3—melanoma	1e-05	0.000166	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NRAS—melanoma	1e-05	0.000166	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VEGFA—melanoma	9.92e-06	0.000164	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STAT3—melanoma	9.82e-06	0.000162	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NRAS—melanoma	9.8e-06	0.000162	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK3—melanoma	9.59e-06	0.000159	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK3—melanoma	9.38e-06	0.000155	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MYC—melanoma	9.33e-06	0.000154	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CD—melanoma	9.27e-06	0.000153	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALB—melanoma	9.15e-06	0.000151	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK1—melanoma	9.13e-06	0.000151	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MYC—melanoma	9.12e-06	0.000151	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EGFR—melanoma	9.12e-06	0.000151	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK1—melanoma	8.93e-06	0.000148	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EGFR—melanoma	8.92e-06	0.000148	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KRAS—melanoma	8.62e-06	0.000142	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KRAS—melanoma	8.43e-06	0.000139	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CB—melanoma	8.08e-06	0.000133	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTGS2—melanoma	8e-06	0.000132	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	7.92e-06	0.000131	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	7.75e-06	0.000128	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TP53—melanoma	7.66e-06	0.000127	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TP53—melanoma	7.49e-06	0.000124	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HRAS—melanoma	7.33e-06	0.000121	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HRAS—melanoma	7.17e-06	0.000118	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL6—melanoma	7.01e-06	0.000116	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTEN—melanoma	6.98e-06	0.000115	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL6—melanoma	6.86e-06	0.000113	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT1—melanoma	6.47e-06	0.000107	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT1—melanoma	6.33e-06	0.000105	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CA—melanoma	4.92e-06	8.14e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKT1—melanoma	4.02e-06	6.65e-05	CbGpPWpGaD
